Regulation of human neurotropic JC virus replication by alternative splicing factor SF2/ASF in glial cells

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Sariyer, Ilker Kudret ^a   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP1; SELF SPLICING RIBOSOMAL RNA; SHORT HAIRPIN RNA; SPLICING FACTOR 2 PROTEIN; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SERINE ARGININE RICH SPLICING PROTEINS; SERINE-ARGININE-RICH SPLICING PROTEINS; VIRUS DNA;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ARTICLE; ASTROCYTE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FETUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIA CELL; HUMAN; HUMAN CELL; JC VIRUS; NONHUMAN; PLASMID; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; GENE EXPRESSION REGULATION; GENETICS; GLIA; HOST PATHOGEN INTERACTION; PHYSIOLOGY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VIROLOGY; VIRUS ACTIVATION;

JC POLYOMAVIRUS;

DNA, VIRAL; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; NEUROGLIA; NUCLEAR PROTEINS; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 79551641727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014630     Document Type: Article

References (34)

1. Weber T (2008) Progressive Multifocal Leukoencephalopathy. Neurol Clin 26: 833-854.
2. Imperiale MJ, Major EO (2007) Polyomaviruses. In: Knipe DM, Howley PM, eds;Fields Virology, 5th edition Philadelphia: Lippincott, Williams & Wilkins, 2263-2298.
3. Berger JR, Concha M (1995) Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirology 1: 5-18.
4. Safak M, Major E, Khalili K (2005) Human polyomavirus, JC virus, and progressive multifocal encephalopathy. In: Howard IG, Gendelman E, Ian Paul Everall, Stuart A. Lipton, SusanSwindells, eds. The Neurology of AIDS. New York: Oxford University Press. pp 461-474.
5. Miller JR, Barrett RE, Britton CB, Tapper ML, Bahr GS, et al. (1982) Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med 307(23): 1436-8.
6. Eng PM, Turnbull BR, Cook SF, Davidson JE, Kurth T, et al. (2006) Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population. Neurology 67(5): 884-6.
7. Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, et al. (2005) Natalizumab induction and maintenance therapy for Crohn's disease. International Efficacy of Natalizumab as Active Crohn's Therapy (ENACT-1) Trial Group; Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group. N Engl J Med 353(4): 375-81.
8. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353(4): 375-81.
9. Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353(4): 369-74.
10. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, et al. (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: A Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10(8): 816-24.
11. Trowbridge PW, Frisque RJ (1995) Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. Neurovirol 1(2): 195-206.
12. Licatalosi DD, Darnell RB (2010) RNA processing and its regulation: global insights into biological networks. Nat Rev Genet 11(1): 75-87.
13. Manley JL, Tacke R (1996) SR proteins and splicing control. Genes & Devl 10: 1569-1579.
14. Graveley BR (2000) Sorting out the complexity of SR protein functions. RNA 6: 1197-1211.
15. Sanford SR, Ellis JD, Cazalla D, Caceres JF (2005) Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/ alternative splicing factor. PNAS 102(42): 15042-15047.
16. Caceres JF, Misteli T, Screaton GR, Spector DL, Krainer AR (1997) Role of the modular domains of SR proteins in subcellular localization and alternative splicing specificity. J Cell Biol 118(2): 225-238.
17. Ge H, Manley LJ (1990) A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 13; 62(1): 25-34.
18. Wang J, Manley JL (1995) Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1(3): 335-46.
19. White MK, Safak M, Khalili K (2009) Regulation of gene expression in primate polyomaviruses. J Virol 83(21): 10846-56.
20. White MK, Khalili K (2006) Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses. Oncogene, 25(38): 5286-93.
21. Zuo P, Manley JL (1993) Functional domains of the human splicing factor ASF/ SF2. EMBO J 2(12): 4727-37.
22. Cazalla D, Zhu J, Manche L, Huber E, Krainer AR, et al. (2002) Nuclear export and retention signals in the RS domain of SR proteins. Mol Cell Biol 22(19): 6871-82.
23. Akan I, Sariyer IK, Biffi R, Palermo V, Woolridge S, et al. (2006) Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 349(1): 66-78.
24. Radhakrishnan S, Otte J, Enam S, Del Valle L, Khalili K, et al. (2003) JC virusinduced changes in cellular gene expression in primary human astrocytes. J Virol 77(19): 10638-44.
25. Krynska B, Del Valle L, Gordon J, Otte J, Croul S, et al. (2000) Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology 274(1): 65-74.
26. Major EO, Miller AE, Mourrain P, Traub RG, Width de E Sever J (1985) Establishment of a line of human fetal glial cells that supports JC virus multiplication. PNAS 82: 1257-1261.
27. Sariyer IK, Akan I, Palermo V, Gordon J, Khalili K, et al. (2006) Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J Virol 80(8): 3893-903.
28. Sariyer IK, Safak M, Gordon J, Khalili K (2009) Generation and characterization of JCV permissive hybrid cell lines. J Virol Methods 159(1): 122-6.
29. Luckow B, Schutz G (1987) CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 15: 5490.
30. Kinoshita Y, Johnson EM (2004) Site-specific loading of an MCM protein complex in a DNA replication initiation zone upstream of the c-MYC gene in the HeLa cell cycle. J Biol Chem 279: 35879-35889.
31. Song Y, Wilkins P, Hu W, Murthy KS, Chen J, et al. (2007) Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells. Biochem J 406(3): 427-36.
32. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33(3): 401-6.
33. Sariyer IK, Khalili K, Safak M (2008) Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: Inhibition by small t antigen. Virology 375(2): 464-79.
34. Romagnoli L, Sariyer IK, Tung J, Feliciano M, Sawaya BE, et al. (2008) Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology 375(2): 331-41.